Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews...
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • Reparative Immunology (Jul 2019)
    • Allergy (Apr 2019)
    • Biology of familial cancer predisposition syndromes (Feb 2019)
    • Mitochondrial dysfunction in disease (Aug 2018)
    • Lipid mediators of disease (Jul 2018)
    • Cellular senescence in human disease (Apr 2018)
    • View all review series...
  • Collections
    • Recently published
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Scientific Show Stoppers
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • About
  • Editors
  • Consulting Editors
  • For authors
  • Current issue
  • Past issues
  • By specialty
  • Subscribe
  • Alerts
  • Advertise
  • Contact
  • Conversations with Giants in Medicine
  • Author's Takes
  • Recently published
  • Brief Reports
  • Technical Advances
  • Commentaries
  • Editorials
  • Hindsight
  • Review series
  • Reviews
  • The Attending Physician
  • First Author Perspectives
  • Scientific Show Stoppers
  • Top read articles
  • Concise Communication
Renal cell–expressed TNF receptor 2, not receptor 1, is essential for the development of glomerulonephritis
Volker Vielhauer, … , George Stavrakis, Tanya N. Mayadas
Volker Vielhauer, … , George Stavrakis, Tanya N. Mayadas
Published May 2, 2005
Citation Information: J Clin Invest. 2005;115(5):1199-1209. https://doi.org/10.1172/JCI23348.
View: Text | PDF
Categories: Article Nephrology

Renal cell–expressed TNF receptor 2, not receptor 1, is essential for the development of glomerulonephritis

  • Text
  • PDF
Abstract

TNF is essential for the development of glomerulonephritis, an immune-mediated disorder that is a major cause of renal failure worldwide. However, TNF has proinflammatory and immunosuppressive properties that may segregate at the level of the 2 TNF receptors (TNFRs), TNFR1 and TNFR2. TNFR1-deficient mice subjected to immune complex–mediated glomerulonephritis developed less proteinuria and glomerular injury, and fewer renal leukocyte infiltrates at early time points after disease induction, and this was associated with a reduced systemic immune response to nephrotoxic rabbit IgG. However, proteinuria and renal pathology were similar to those in wild-type controls at later time points, when lack of TNFR1 resulted in excessive renal T cell accumulation and an associated reduction in apoptosis of these cells. In sharp contrast, TNFR2-deficient mice were completely protected from glomerulonephritis at all time points, despite an intact systemic immune response. TNFR2 was induced on glomerular endothelial cells of nephritic kidneys, and TNFR2 expression on intrinsic cells, but not leukocytes, was essential for glomerulonephritis and glomerular complement deposition. Thus, TNFR1 promotes systemic immune responses and renal T cell death, while intrinsic cell TNFR2 plays a critical role in complement-dependent tissue injury. Therefore, therapeutic blockade specifically of TNFR2 may be a promising strategy in the treatment of immune-mediated glomerulonephritis.

Authors

Volker Vielhauer, George Stavrakis, Tanya N. Mayadas

×

Figure 5

Options: View larger image (or click on image) Download as PowerPoint
TNFR1-deficient mice are protected from nephritis at day 7 but not at da...
TNFR1-deficient mice are protected from nephritis at day 7 but not at days 21 and 42 after injection of nephrotoxic serum. (A) Albuminuria in TNFR1-deficient mice was absent at day 7 but comparable to that of wild-type at days 14 and 21 (n = 6–8 per group). (B) Hypoalbuminemia was absent in TNFR1-deficient mice at day 7 but was comparable to that of wild-type at later time points. Serum levels for cholesterol and creatinine were normal in wild-type and TNFR1-deficient mice at day 7 and were similarly elevated at day 42 (n = 6–8 per group). The dotted lines indicate baseline values observed in normal wild-type mice. Data represent the mean ± SEM. **P < 0.01, ***P < 0.001 compared with wild-type.
Follow JCI:
Copyright © 2019 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts